ALPHA TRIBE

Laurus Labs LimitedImportant, 26-06-2025: General Updates

26-06-2025 | 11:54 am

Laurus Labs has invested ₹39.99 Cr in its subsidiary Laurus Bio by acquiring 15,414 Series A2 Compulsorily Convertible Preference Shares through a private placement at a substantial premium. This strategic infusion strengthens Laurus Bio’s capital base, supporting its growth initiatives in the biotech segment.

No comments yet. Be the first to comment!

All announcements from Laurus Labs Limited